https://www.selleckchem.com/pr....oducts/anlotinib-al3
Risk-stratification with the sFlt-1/PlGF cutoff values into high- (85), intermediate- (38-85), and low-risk ( less then 38) showed a significantly shorter time to delivery in high- and intermediate- versus low-risk patients (4 versus 8 versus 29 days). When integrating all available clinical information into a multimarker model, an area under the curve of 88.7% corresponding to a sensitivity, specificity, positive and negative predictive value of 80.0%, 87.3%, 75.0%, and 90.2% was reached. The sFlt-1/PlGF-ratio alone was in
Like
Comment
Share
